JOURNAL ARTICLE

Exercise-Induced Pulmonary Arterial Hypertension

Abstract

Background— The clinical relevance of exercise-induced pulmonary arterial hypertension (PAH) is uncertain, and its existence has never been well studied by direct measurements of central hemodynamics. Using invasive cardiopulmonary exercise testing, we hypothesized that exercise-induced PAH represents a symptomatic stage of PAH, physiologically intermediate between resting pulmonary arterial hypertension and normal. Methods and Results— A total of 406 consecutive clinically indicated cardiopulmonary exercise tests with radial and pulmonary arterial catheters and radionuclide ventriculographic scanning were analyzed. The invasive hemodynamic phenotype of exercise-induced PAH (n=78) was compared with resting PAH (n=15) and normals (n=16). Log-log plots of mean pulmonary artery pressure versus oxygen uptake (V̇ o 2 ) were obtained, and a “join-point” for a least residual sum of squares for 2 straight-line segments (slopes m1, m2) was determined; m2<m1=“plateau,” and m2>m1=“takeoff” pattern. At maximum exercise, V̇ o 2 (55.8±20.3% versus 66.5±16.3% versus 91.7±13.7% predicted) was lowest in resting PAH, intermediate in exercise-induced PAH, and highest in normals, whereas mean pulmonary artery pressure (48.4±11.1 versus 36.6±5.7 versus 27.4+3.7 mm Hg) and pulmonary vascular resistance (294±158 versus 161±60 versus 62±20 dyne · s · cm −5 , respectively; P <0.05) followed an opposite pattern. An exercise-induced PAH plateau (n=32) was associated with lower V̇ o 2 max (60.6±15.1% versus 72.0±16.1% predicted) and maximum cardiac output (78.2±17.1% versus 87.8±18.3% predicted) and a higher resting pulmonary vascular resistance (247±101 versus 199±56 dyne · s · cm −5 ; P <0.05) than takeoff (n=40). The plateau pattern was most common in resting PAH, and the takeoff pattern was present in nearly all normals. Conclusions— Exercise-induced PAH is an early, mild, and clinically relevant phase of the PAH spectrum.

Keywords:
Medicine Cardiology Pulmonary hypertension Internal medicine

Metrics

347
Cited By
21.06
FWCI (Field Weighted Citation Impact)
46
Refs
1.00
Citation Normalized Percentile
Is in top 1%
Is in top 10%

Citation History

Topics

Pulmonary Hypertension Research and Treatments
Health Sciences →  Medicine →  Pulmonary and Respiratory Medicine
Cardiovascular Effects of Exercise
Health Sciences →  Medicine →  Cardiology and Cardiovascular Medicine
Cardiovascular Function and Risk Factors
Health Sciences →  Medicine →  Cardiology and Cardiovascular Medicine
© 2026 ScienceGate Book Chapters — All rights reserved.